CLOV vs URGN · rev $1.37B vs rev $24.6M
Clover Health Investments Corp (CLOV) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported URGN revenue for 2024-12-31 was $24.6M. Net income was -$37.5M. Revenue was down 2.5% from 2024-09-30 to 2024-12-31. URGN currently screens at market cap $1.61B.
CLOV currently screens at market cap $1.55B. URGN currently screens at market cap $1.61B.
Not investment advice. Open the CLOV and URGN stock pages for the full models.
Not investment advice.